Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Deficits in integrative NMDA receptors caused by Grin1 disruption can be rescued in adulthood
    Published on 2023-06-22
    3 years ago
  • No time to lose: the current state of research in rapid-acting psychotherapeutics
    Published on 2023-06-22
    3 years ago
  • A novel rat model of potentiated incubation of opioid craving after abstinence induced by adverse consequences of drug seeking
    Published on 2023-06-22
    3 years ago
  • Ketamine in neuropsychiatric disorders: an update
    Published on 2023-06-20
    3 years ago
  • Exploring the multiverse: the impact of researchers’ analytic decisions on relationships between depression and inflammatory markers
    Published on 2023-06-19
    3 years ago
  • Microglia depletion facilitates the display of maternal behavior and alters activation of the maternal brain network in nulliparous female rats
    Published on 2023-06-17
    3 years ago
  • Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis
    Published on 2023-06-15
    3 years ago
« Previous 1 … 125 126 127 128 129 … 143 Next »
Journal of Psychopharmacology
  • Resting state fMRI reveals differential effects of glucose administration on central appetite signalling in young and old adults
    Published on 2020-01-07
    7 years ago
  • Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
    Published on 2019-12-12
    7 years ago
  • Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile
    Published on 2019-12-09
    7 years ago
  • Effects of long-term antipsychotics treatment on body weight: A population-based cohort study
    Published on 2019-11-14
    7 years ago
  • Effects of an adenosine A2A agonist on the rewarding associative properties of nicotine and neural plasticity in a rodent model of schizophrenia
    Published on 2019-11-07
    7 years ago
  • Pro-cognitive effect of upregulating cyclic guanosine monophosphate signalling during memory acquisition or early consolidation is mediated by increased AMPA receptor trafficking
    Published on 2019-11-06
    7 years ago
  • Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication
    Published on 2019-11-06
    7 years ago
« Previous 1 … 125 126 127 128 129 … 150 Next »
European Neuropsychopharmacology
  • ECNP Calendar of Meetings
    Published on 2021-01-30
    5 years ago
  • EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial
    Published on 2021-01-26
    6 years ago
  • Corrigendum to “Translating big data to better treatment in bipolar disorder – a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]”
    Published on 2021-01-24
    6 years ago
  • Integrating genomics and transcriptomics: Towards deciphering ADHD
    Published on 2021-01-24
    6 years ago
  • Increased thin-spine density in frontal cortex pyramidal neurons in a genetic rat model of schizophrenia-relevant features
    Published on 2021-01-22
    6 years ago
  • Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers
    Published on 2021-01-22
    6 years ago
  • Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis
    Published on 2021-01-20
    6 years ago
« Previous 1 … 125 126 127 128 129 … 168 Next »

   Pharma Pub